Dentsply Sirona Inc (XRAY) Stock Price, Quote & News

Company Profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 844 848 0137

Website: www.dentsplysirona.com

Address:

13320 Ballantyne Corporate Place, Charlotte, United States

Wonderfulnewz Aug. 6 at 6:57 PM

$XRAY it’s cheap and it’s global and it *should* be bottoming here. Nvst did great considering the environment. I’m wondering if the algn swan dive has everyone spooked or if we’ll have a “new ceo throws all write downs out there on their 1st quarter” type situation. Options market isn’t optimistic

0 · Reply

jam1128 Aug. 6 at 11:59 AM

$XRAY Thoughts on the CEO change up?

1 · Reply

ZacksResearch Aug. 4 at 12:50 PM

$XRAY Q2 earnings preview: Can innovation and strategic initiatives offset macro pressures? 🤔 🌐 Imaging momentum from Orthophos SL & Primescan 2 could boost European & APAC growth. ⚖️ U.S. faces softer spending and competitive strain, while Byte's challenges weigh on organic sales by approximately two percentage points. 📊 Gross margins might improve as restructuring savings kick in. Full analysis here 👉 https://www.zacks.com/stock/news/2661509/dentsply-sirona-to-post-q2-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2661509-body-5598&ADID=SYND_STOCKTWITS_TWEET_2_2661509_BODY_5598

0 · Reply

ZacksResearch Aug. 4 at 11:38 AM

$XRAY earnings on deck — bullish breakout or more pain ahead? Imaging and SureSmile likely boosted Q2 results, but Byte and macro headwinds may have weighed on revenue momentum. Full setup before the report 👉 https://www.zacks.com/stock/news/2661509/dentsply-sirona-to-post-q2-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2661509-teaser-5587&ADID=SYND_STOCKTWITS_TWEET_2_2661509_TEASER_5587

0 · Reply

11thestate Aug. 1 at 10:42 AM

Dentsply Sirona has agreed to an $84M settlement with $XRAY investors over claims it misled them about financial reporting and anti-competitive practices. 📅 Class Period: December 8, 2015 – August 6, 2018 🗓️ Claim Deadline: October 7, 2025 If you bought $XRAY during this time, you can file a claim for payment here: https://11th.com/cases/dentsplysirona-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=dailyposts&utm_content=08012025_1

0 · Reply

CeaseNDesist Jul. 31 at 1:44 PM

$XRAY why the drop off?

0 · Reply

11thestate Jul. 24 at 12:01 PM

#DentsplySirona has agreed to an $84M settlement with $XRAY investors over claims it misled them about financial reporting and anti-competitive practices. ⏳ Claim deadline: October 7, 2025 📅 Class Period: December 8, 2015 – August 6, 2018 If you bought $XRAY during this period, you can file a claim for payment here: https://11th.com/cases/dentsplysirona-investor-settlement

0 · Reply

JarvisFlow Jul. 22 at 2:31 PM

Barrington Research has updated their rating for Dentsply Sirona ( $XRAY ) to Outperform with a price target of 21.

0 · Reply

AlphaRR Jul. 21 at 9:27 PM

$MEDP one of my long term holdings picked up during Covid era . Great solid play on Pharma without the risk of a trial not working. Sold half kept half , this is a hell of a spike , but if you think about they raised guidance to $15 in earnings , so at 460 it's only 30x PE not so bad So I kept half A name not talked about often but a solid growth play , those earnings were strong as fuck! One day I'll have the same type of returns on the 2 med techs I bought today $XRAY and $GMED

0 · Reply

AlphaRR Jul. 21 at 2:22 PM

Added to one of my long time holdings , $GMED solid mid cap med device company and some new products should accelerate revenue from their large acquisition they did . CFO is stepping in , Board has full visibility into the CFO, the hire is likely a good one. Reaffirmed guidance. Cheap! CEO is great , he wasn't to $XRAY , added xray today for first time . CEO was on xray board, he had full visibility, for xray to attract this guy , it has to be a really good opportunity as its a much smaller company, he wouldn't have left gmed otherwise . Xray is cheap , huge dividend and cheap. Both companies are strong acquisition candidates because of the new administration being much friendlier to m&A

0 · Reply

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Jul 14, 2025, 9:26 AM EDT - 23 days ago

Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D

Jul 10, 2025, 8:30 AM EDT - 27 days ago

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Jun 17, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation

Jun 15, 2025, 10:00 AM EDT - 7 weeks ago

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 7 weeks ago

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect

Jun 9, 2025, 8:30 AM EDT - 2 months ago

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY

Jun 8, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation

Jun 5, 2025, 5:35 PM EDT - 2 months ago

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

Jun 5, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation

Jun 4, 2025, 6:34 PM EDT - 2 months ago

Buying Dentsply Sirona

Jun 1, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out

May 29, 2025, 4:30 PM EDT - 2 months ago

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

May 29, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect

May 27, 2025, 4:15 PM EDT - 2 months ago

Dentsply Sirona Declares Quarterly Cash Dividend

May 27, 2025, 10:00 AM EDT - 2 months ago

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 25, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation

May 22, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Investors to Inquire about Securities Investigation

May 19, 2025, 7:00 AM EDT - 2 months ago

Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference

May 15, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Shareholders to Inquire about Securities Investigation

May 13, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Shareholders to Connect

May 8, 2025, 1:31 PM EDT - 3 months ago

Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It?

May 8, 2025, 10:04 AM EDT - 3 months ago

DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:00 AM EDT - 3 months ago

Dentsply Sirona Reports First Quarter 2025 Results

Apr 22, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Investors to Reach Out

Apr 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Shareholders to Reach Out

Apr 9, 2025, 7:00 AM EDT - 4 months ago

Dentsply Sirona to Host First Quarter Conference Call on May 8th

Apr 4, 2025, 8:50 AM EDT - 4 months ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

BMY VTRS

Mar 17, 2025, 8:45 AM EDT - 5 months ago

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

Mar 17, 2025, 8:35 AM EDT - 5 months ago

Europe Dental Imaging Device Market Analysis 2025-2031, with Focus on Key Market Leaders including Dentsply Sirona, Carestream Dental, 3Shape and more

Mar 14, 2025, 6:12 AM EDT - 5 months ago

Dental Burs Market Trends Analysis Report 2025-2030, with Profiles of Dentsply Sirona, Coltene, Shofu, MANI, Brasseler USA, American Orthodontics, Prima Dental, Diatech, Komet Dental & Envista

Mar 13, 2025, 2:35 PM EDT - 5 months ago

Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst

ZIMV

Mar 11, 2025, 11:05 AM EDT - 5 months ago

Dental Sterilization Market Forecast Report 2025-2030, with Key Players Hu-Friedy, Dentsply Sirona, Midmark, Matachana, W&H Dentalwerk, Nakanishi, SciCan, Getinge and Tuttnauer U.S.A.

Mar 4, 2025, 4:30 PM EST - 5 months ago

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025

Feb 27, 2025, 4:01 PM EST - 5 months ago

DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:00 AM EST - 5 months ago

Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook

Feb 11, 2025, 8:30 AM EST - 6 months ago

Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare

Feb 6, 2025, 8:30 AM EST - 6 months ago

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

Jan 27, 2025, 4:30 PM EST - 6 months ago

Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th

Wonderfulnewz Aug. 6 at 6:57 PM

0 · Reply

jam1128 Aug. 6 at 11:59 AM

$XRAY Thoughts on the CEO change up?

1 · Reply

ZacksResearch Aug. 4 at 12:50 PM

0 · Reply

ZacksResearch Aug. 4 at 11:38 AM

0 · Reply

11thestate Aug. 1 at 10:42 AM

0 · Reply

CeaseNDesist Jul. 31 at 1:44 PM

$XRAY why the drop off?

0 · Reply

11thestate Jul. 24 at 12:01 PM

0 · Reply

JarvisFlow Jul. 22 at 2:31 PM

Barrington Research has updated their rating for Dentsply Sirona ( $XRAY ) to Outperform with a price target of 21.

0 · Reply

AlphaRR Jul. 21 at 9:27 PM

0 · Reply

AlphaRR Jul. 21 at 2:22 PM

0 · Reply

ZacksResearch Jul. 16 at 5:54 PM

$XRAY down 16.1% YTD — What’s holding it back? 🦷 Despite strong Q1 results and a promising digital implant workflow, European demand softness and forex headwinds are weighing on the stock. Find out what could drive XRAY’s recovery here 👉 https://www.zacks.com/stock/news/2586094/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2586094-body-2183&ADID=SYND_STOCKTWITS_TWEET_2_2586094_BODY_2183

0 · Reply

ZacksResearch Jul. 16 at 4:13 PM

$XRAY gaining momentum — is this the turning point? Digital implant traction, strong R&D, and Q1 margin growth are driving the story, even with softness in Europe. See why XRAY could belong in your portfolio now 👉 https://www.zacks.com/stock/news/2586094/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2586094-teaser-2139&ADID=SYND_STOCKTWITS_TWEET_2_2586094_TEASER_2139

0 · Reply

11thestate Jul. 15 at 12:20 PM

Dentsply Sirona has agreed to an $84M settlement with $XRAY investors over claims that it misled them about financial reporting and anti-competitive practices. If you bought $XRAY between December 8, 2015, and August 6, 2018, you can file a claim for payment here: https://11th.com/cases/dentsplysirona-investor-settlement

1 · Reply

Ferrari360 Jul. 12 at 11:50 AM

$XRAY Filled 1000 yesterday. Going higher

0 · Reply

Rage_Against_The_Machine Jul. 8 at 2:48 PM

Dental bone graft market projected to reach $1.1B by 2031 (7.21% CAGR) - $XRAY named as key player. While sector tailwinds from aging populations and cosmetic dentistry grow, Dentsply's 13.6x Debt/EBITDA and revenue declines demand scrutiny. Bullish on market, neutral on execution risk. https://www.prnewswire.com/news-releases/dental-bone-graft-and-substitutes-market-to-hit-usd-1-098-48-million-by-2031--global-outlook--forecast-at-7-21-cagr--the-insight-partners-302500190.html

0 · Reply

RavaK Jul. 7 at 8:21 PM

$XRAY omg I was about to buy at market open and then thought better. Dodged a bullet with that cancel order

0 · Reply

11thestate Jul. 7 at 12:32 PM

COMING SOON - $XRAY 📅 ➡️ https://11th.com/cases/dentsplysirona-investor-settlement

1 · Reply

efficiency Jul. 3 at 11:44 AM

$XRAY

0 · Reply

ChristopherBrecher Jul. 3 at 11:40 AM

$XRAY Another possible long idea.

0 · Reply

Idahomike1 Jul. 2 at 1:32 AM

$XRAY Bullish!

0 · Reply

11thestate Jun. 30 at 11:05 AM

$XRAY is down 60% from its highs. #DentsplySirona investors — don’t miss your chance to claim what you’re owed. Full details: https://11th.com/cases/dentsplysirona-investor-settlement

0 · Reply

11thestate Jun. 26 at 10:21 AM

$XRAY investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #DentsplySirona $XRAY https://11th.com/cases/dentsplysirona-investor-settlement

1 · Reply

Market Cap	2.85B
Revenue (ttm)	3.79B
Net Income (ttm)	-910.00M
EPS (ttm)	N/A
PE Ratio	8.52
Forward PE	7.54
Profit Margin	-23.99%
Debt to Equity Ratio	0.79

Volume	5,608,500
Avg Vol	2,703,630
Day's Range	N/A - N/A
Shares Out	199.29M
Stochastic %K	1%
Beta	0.94
Analysts	Sell
Price Target	$18.23